Archives

by in
Entry Author Date Location
Sage Therapeutics Grabs $38M More For CNS Drugs 03/13/14 Boston
Partnership with AnaptysBio Gives Tesaro Entrée to Immuno-Oncology 03/13/14 San Diego
Get a Shot, Have Some Bread: ImmusanT’s Plan For a Celiac Vaccine 03/11/14 Boston
Brushing Off Clinical Setback, Cerulean Tees Up $75M IPO 03/10/14 Boston
East Coast Biotech Roundup: VentriNova, RainDance, Biogen, & More 03/07/14 Boston
Farewell, Xconomy Readers. I’m Going to Climb a New Mountain 03/05/14 National
Biogen, Eisai Join Up in Alzheimer’s Drug Pact 03/05/14 Boston
RainDance, Angling For an IPO, Adds $16.5M From GE Ventures, Others 03/03/14 Boston
PacBio, the Post-Hype Sleeper of Genomics 03/03/14 National
East Coast Biotech Roundup: Sigal, Radius, SHIN-NY, & More 02/28/14 Boston
Revamped Radius Health Looks to Cash In With $86M IPO 02/27/14 Boston
New York’s Life Science Disruptors on March 6: Here’s the Agenda 02/26/14 New York
Elliott Sigal, Bristol’s Former R&D Chief, on Life After Big Pharma 02/25/14 New York
Hiring in Biotech is Tricky. But Algorithms Won’t Save the Day 02/24/14 National
Isis Shares Climb on Early Data for Rare Spine Disorder Drug 02/21/14 Boston
East Coast Biotech Roundup: HART, CoStim, Forest/Actavis, & More 02/21/14 Boston
Immuno-Oncology Fever Rages as Novartis Snaps Up CoStim 02/18/14 Boston
Ex-Harvard Bio Prez Leads Spin-Off’s Plan to Make Engineered Organs 02/18/14 Boston
Molecular Diagnostics Are in a Rut. The Industry Needs the FDA 02/17/14 National
East Coast Biotech Roundup: Voyager, Concert, Retrophin, & More 02/14/14 Boston
Concert Pharma Heads to Nasdaq, Prices IPO at $14 Per Share 02/13/14 Boston
Third Rock’s Voyager Hunts For CNS Disorders With Gene Therapy 02/12/14 Boston
Flexion Prices IPO at $13, Heads to Nasdaq Tomorrow 02/11/14 Boston
The Young and Proven Biotech VCs From 2012. Where Are They Now? 02/10/14 National
East Coast Biotech Roundup: Genocea, Eleven, NIH/Pharma, & More 02/07/14 Boston
Eleven Prices IPO Below Projected Range, Grabs $50M 02/06/14 Boston
Vaccine Developer Genocea Prices IPO at $12 Per Share 02/05/14 Boston
The $1K Genome? So What? Illumina Is On a Quest for World Domination 02/03/14 National
Hunting For Brain Plaques, Neurophage Turns to a Virus 01/31/14 Boston
Dicerna Shares Triple on First Trading Day, Close at $46 01/30/14 Boston
Page 2 of 82 « previous page · next page »